Global Cell-based Assays Market: Overview
The cell-based assay is the method of study of living cell depending upon distinct parameters. They are used to quantify practically of biochemical or cellular functions. Functional cells are utilized in cell-based assays as diagnostic equipment in the study for new drugs. The cell-based assays are extensively used in academic research institutes, government institutions, biotechnology companies, pharmaceutical companies, contract research organizations, and others. The cell-based assays aid in evaluating cell motility, cell toxicity, cell proliferation, morphology in drug discovery & diagnostics, and generation of a quantifiable product. They also assist study in the domains of cancer, stem cells, immunology, and others. Thus, owing to the increasing demand for cell-based assays, the global market is assumed to grow in the coming period.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
Global Cell-based Assays Market: Growth Factors
Rising R&D expenditure on research, their growing implementation in drug discovery, improvements in automation, advantages of cell-based assays over other techniques, and high-throughput techniques are few of the major factors that are contributing in propelling the growth of global cell-based assays market. However, strict regulatory recommendation and huge price of devices may hinder the growth of the market.
Global Cell-based Assays Market: Segmentation
The global cell-based assays market can be segmented based on application, product, end-user, and region. The application segment of the market is divided into ADME studies, predictive toxicology, drug discovery, basic research, and other applications. The product segment of the global market is classified into reagents & assay kits, instruments, microplates, consumables, services, cell lines, software, and other consumables. The reagents & assay kits segment of the market is sub-segmented into cell growth assays, second messenger assays, cell death assays, reporter gene assays, and other assays. The cell lines segment of the market is classified into primary cell lines, stem cell lines, and immortalized cell lines. The end-user segment of the market is diversified into academic & government institutions, pharmaceutical & biotechnology companies, contract research organizations, and other end-users. Regionally, the global cell-based assays market is sub-segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Global Cell-based Assays Market: Regional Analysis
North America is anticipated to be the dominating region in the global cell-based assays market. The growth of this region can be attributed to factors such as the existence of great pharmaceutical companies in this region, their dedication toward drug-based development and research, and increasing existence of superior biotechnology laboratories. Asia-Pacific region is also expected to grow at a higher rate in the near future.
Global Cell-based Assays Market: Competitive Players
The key players in the global cell-based assays market are Danaher Corporation, GE Healthcare Life Sciences, Becton, Dickinson and Company, BioVision Inc., Merck & Co, Inc., Thermo Fisher Scientific, Inc., and PerkinElmer, Inc. The other major players in the market are Caliper Life Sciences Inc., Cell Signaling Technology, Inc., Sigma-Aldrich, Cisbio Bioassays, General Electric Company, Promega Corporation, and DiscoveRx.
Global Cell-based Assays Market: Regional Segment Analysis
What Report Provides
Request the coronavirus impact analysis across industries and markets